REFERENCES
1. J. Larry Jameson, Dennis L. Kasper, Dan L. Longo, Anthony S. Fauci, Stephen L. Hauser JL, ed. Disorders of Immune-Mediated Injury. In:Harrison’s Principles of Internal Medicine . 20th Editi. New York : McGraw-Hill Education; 2018:2600-2607.
2. Yahalom M, Koren O, Turgeman Y. High Degree Atrioventricular Block Complicated Cardiac Sarcoidosis : Case Report. 2018:157-163. doi:10.4236/wjcs.2018.89015
3. Nunes H, Freynet O, Naggara N, et al. Cardiac Sarcoidosis.Semin Respir Crit Care Med . 2010;31(04):428-441. doi:10.1055/s-0030-1262211
4. Hulten E, Aslam S, Osborne M, Abbasi S, Bittencourt MS, Blankstein R. Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther . 2016;6(1):50-63. doi:10.3978/j.issn.2223-3652.2015.12.13
5. Jotterand M, Grabherr S, Lobrinus JA, Michaud K. Sudden cardiac death and sarcoidosis of the heart in a young patient. Cardiovasc Pathol . 2017;28:18-20. doi:10.1016/j.carpath.2017.01.003
6. Kandolin R, Lehtonen J, Graner M, et al. Diagnosing isolated cardiac sarcoidosis. J Intern Med . 2011;270(5):461-468. doi:10.1111/j.1365-2796.2011.02396.x
7. Sekhri V, Sanal S, Delorenzo LJ, Aronow WS, George P. Review paper Cardiac sarcoidosis : a comprehensive review. 2011. doi:10.5114/aoms.2011.24118
8. Perry A, Vuitch F. Causes of death in patients with sarcoidosis: A morphologic study of 38 autopsies with clinicopathologic correlations.Arch Pathol Lab Med . 1995;119(2):167-172.
9. Judson MA. The diagnosis of sarcoidosis. Curr Opin Pulm Med . 2019;25(5):484-496. doi:10.1097/MCP.0000000000000596
10. Birnie DH, Nery PB, Ha AC, Beanlands RSB. Cardiac Sarcoidosis. 2016;68(4). doi:10.1016/j.jacc.2016.03.605
11. Judson MA. Screening sarcoidosis patients for cardiac sarcoidosis: What the data really show. Respir Med . 2019;154:155-157. doi:10.1016/j.rmed.2019.05.007
12. Tan JL, Fong HK, Birati EY, Han Y. Cardiac Sarcoidosis. Am J Cardiol . 2019;123(3):513-522. doi:10.1016/j.amjcard.2018.10.021
13. Evanchan JP, Crouser ED. Cardiac Sarcoidosis : Recent Advances in Diagnosis and Treatment and an Argument for the Need for a Systematic Multidisciplinary Approach to Management. 2013;4(March):1160-1174. doi:10.19102/icrm.2013.040308
14. Selan JC, Michaelson M, Fanburg BL, Estes NAM. Evaluation and management of heart rhythm disturbances due to cardiac sarcoidosis.Hear Lung Circ . 2014;23(12):1100-1109. doi:10.1016/j.hlc.2014.07.065
15. Orii M, Tanimoto T, Ota S, et al. Diagnostic accuracy of cardiac magnetic resonance imaging for cardiac sarcoidosis in complete heart block patients implanted with magnetic resonance-conditional pacemaker.J Cardiol . 2020;(2019). doi:10.1016/j.jjcc.2020.02.014
16. Kouranos V, Tzelepis GE, Rapti A, et al. Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis. JACC Cardiovasc Imaging . 2017;10(12):1437-1447. doi:10.1016/j.jcmg.2016.11.019
17. Stanton KM, Ganigara M, Corte P, et al. The Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Cardiac Sarcoidosis.Hear Lung Circ . 2017;26(11):1191-1199. doi:10.1016/j.hlc.2017.02.021
18. Hamzeh N, Steckman DA, Sauer WH, Judson MA. Pathophysiology and clinical management of cardiac sarcoidosis. Nat Rev Cardiol . 2015;12(5):278-288. doi:10.1038/nrcardio.2015.22
19. Birnie DH, Kandolin R, Nery PB, Kupari M. Cardiac manifestations of sarcoidosis: Diagnosis and management. Eur Heart J . 2017;38(35):2663-2670. doi:10.1093/eurheartj/ehw328
20. Kopriva P, Griva M, Tüdös Z. Management of cardiac sarcoidosis – A practical guide. Cor Vasa . 2018;60(2):e155-e164. doi:10.1016/j.crvasa.2017.05.012
21. Ballul T, Borie R, Crestani B, et al. Treatment of cardiac sarcoidosis: A comparative study of steroids and steroids plus immunosuppressive drugs. Int J Cardiol . 2019;276:208-211. doi:10.1016/j.ijcard.2018.11.131
22. Ashraf S, Briasoulis A, Afonso L. Infrequent cardiac manifestations of sarcoidosis. Hear Lung J Acute Crit Care . 2016;45(6):515-516. doi:10.1016/j.hrtlng.2016.08.013
23. Kandolin R, Lehtonen J, Kupari M. Cardiac Sarcoidosis and Giant Cell Myocarditis as Causes of Atrioventricular Block in Young and Middle-Aged Adults. Circ Arrhythmia Electrophysiol . 2011;4(3):303-309. doi:10.1161/CIRCEP.110.959254
24. Birnie DH, Sauer WH, Bogun F, et al. HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis. doi:10.1016/j.hrthm.2014.03.043
25. Nery PB, Beanlands RS, Nair GM, et al. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.J Cardiovasc Electrophysiol . 2014;25(8):875-881. doi:10.1111/jce.12401
26. Salama A, Abdullah AS, Nadkarni N, Alweis R. SARCOIDOSIS INCREASES THE RISK OF COMPLETE HEART BLOCK: A REVIEW FROM THE NATIONAL INPATIENT SAMPLE. J Am Coll Cardiol . 2019;73(9):543. doi:10.1016/s0735-1097(19)31151-9
27. Nordenswan H-K, Lehtonen J, Ekström K, et al. Outcome of Cardiac Sarcoidosis Presenting With High-Grade Atrioventricular Block.Circ Arrhythm Electrophysiol . 2018;11(8):e006145. doi:10.1161/CIRCEP.117.006145
28. Ghanizada M, Rossing K, Bundgaard H, Gustafsson F. DA N I S H M E D I C A L J O U R N A L. Dan Med J . 2018;65(4):A5462.
29. SCHULLER JL, OLSON MD, ZIPSE MM, et al. Electrocardiographic Characteristics in Patients With Pulmonary Sarcoidosis Indicating Cardiac Involvement. J Cardiovasc Electrophysiol . 2011;22(11):1243-1248. doi:10.1111/j.1540-8167.2011.02099.x
30. Gheysens O, Cleemput J Van, Wuyts W. Natural evolution of cardiac sarcoidosis in an asymptomatic patient : a case report. 2019:1-6. doi:10.1093/ehjcr/ytz099
31. Segura AM, Radovancevic R, Demirozu ZT, Frazier OH, Buja LM. Granulomatous myocarditis in severe heart failure patients undergoing implantation of a left ventricular assist device. Cardiovasc Pathol . 2014;23(1):17-20. doi:10.1016/j.carpath.2013.06.005
32. Roberts WC, Roberts CC, Ko JM, Filardo G, Capehart JE, Hall SA. Morphologic features of the recipient heart in patients having cardiac transplantation and analysis of the congruence or incongruence between the clinical and morphologic diagnoses. Med (United States) . 2014;93(5):211-235. doi:10.1097/MD.0000000000000038
33. Statement on Sarcoidosis. Am J Respir Crit Care Med . 1999;160(2):736-755. doi:10.1164/ajrccm.160.2.ats4-99
34. Chapelon-Abric C, Sene D, Saadoun D, et al. Cardiac sarcoidosis: Diagnosis, therapeutic management and prognostic factors. Arch Cardiovasc Dis . 2017;110(8-9):456-465. doi:10.1016/j.acvd.2016.12.014
35. Osborne MT, Hulten EA, Singh A, et al. Reduction in 18F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis. J Nucl Cardiol . 2014;21(1):166-174. doi:10.1007/s12350-013-9828-6
36. Hamzeh N, Steckman DA, Sauer WH, Judson MA. Pathophysiology and clinical management of cardiac sarcoidosis. Nat Rev Cardiol . 2015;12(5):278-288. doi:10.1038/nrcardio.2015.22